FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362665596> ?p ?o ?g. }

• W4362665596 endingPage "06" @default.
• W4362665596 startingPage "01" @default.
• W4362665596 abstract "Background: Clinical trials used Cockcroft-Gault (CG) formula to calculate the estimated glomerular filtration rate (eGFR) in order to dose rivaroxaban for patients with atrial fibrillation (AF). Objectives: The aim of this study is to evaluate rivaroxaban dosing appropriateness in patients with AF with or without renal impairment based on the CG formula and other formulae, including Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation and the isotope dilution mass spectrometry (IDMS) traceable Modification of Diet in Renal Disease (MDRD) Study equation and the associated clinical outcomes. Methodology: A retrospective cohort study conducted at Sultan Qaboos University Hospital (SQUH) from 1st January 2016 to 31st December 2020, included all adult patients (≥ 18 years) treated with rivaroxaban for AF and followed up for one year after starting the treatment. Results: Based on the CG formula, the rivaroxaban dose was inappropriately prescribed in 27% of the patients (21% overdosed and 6% underdosed). Higher baseline creatinine (P=0.0014) and concurrent use of antiplatelet therapy (P<0.001) were associated with the tendency to rivaroxaban overdosing. Higher Body Mass Index (BMI) (P=0.002), female sex (P=0.032), and CKD (P=0.003) were associated with rivaroxaban underdosing. The degree of agreement between the renal function tests when comparing MDRD vs CG and CKD-EPI vs CG in terms of estimated glomerular filtration rate/creatine clearance (eGFR/CrCl) calculation was moderate (κ=0.46) and poor (κ=0.00), respectively, while, in terms of rivaroxaban dose appropriateness was almost perfect (κ=0.82) and substantial (κ=0.77). Clinical outcomes measured by stroke and bleeding events were not significantly different according to the appropriateness of the rivaroxaban dose. Conclusion: This study has shown a relatively high consistency with the gold standard in dosing rivaroxaban in AF patients using CG formula. Treatment efficiency and safety were not affected by the proportion of dose inappropriateness found in this cohort." @default.
• W4362665596 created "2023-04-07" @default.
• W4362665596 creator A5008164811 @default.
• W4362665596 creator A5025644793 @default.
• W4362665596 creator A5039029093 @default.
• W4362665596 creator A5039769355 @default.
• W4362665596 creator A5060205180 @default.
• W4362665596 creator A5068214646 @default.
• W4362665596 creator A5088555356 @default.
• W4362665596 date "2023-04-05" @default.
• W4362665596 modified "2023-09-30" @default.
• W4362665596 title "The Clinical Associations With The Differences in Rivaroxaban Dosing in Patients with Atrial Fibrillation Stratified by three Renal Function Formulae" @default.
• W4362665596 cites W2015754438 @default.
• W4362665596 cites W2121394112 @default.
• W4362665596 cites W2164777277 @default.
• W4362665596 cites W2167423131 @default.
• W4362665596 cites W2320128544 @default.
• W4362665596 cites W2523933248 @default.
• W4362665596 cites W2601739997 @default.
• W4362665596 cites W2615293208 @default.
• W4362665596 cites W2617637649 @default.
• W4362665596 cites W2622276831 @default.
• W4362665596 cites W2738242303 @default.
• W4362665596 cites W2770848480 @default.
• W4362665596 cites W2776428458 @default.
• W4362665596 cites W2790139134 @default.
• W4362665596 cites W2799922239 @default.
• W4362665596 cites W2801592584 @default.
• W4362665596 cites W2801676143 @default.
• W4362665596 cites W2886710144 @default.
• W4362665596 cites W2924769497 @default.
• W4362665596 cites W2943887252 @default.
• W4362665596 cites W2957544571 @default.
• W4362665596 cites W2994305173 @default.
• W4362665596 cites W3046549025 @default.
• W4362665596 cites W3113246977 @default.
• W4362665596 cites W4210264616 @default.
• W4362665596 cites W4221128190 @default.
• W4362665596 cites W4297184648 @default.
• W4362665596 doi "https://doi.org/10.18549/pharmpract.2023.1.2758" @default.
• W4362665596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37090449" @default.
• W4362665596 hasPublicationYear "2023" @default.
• W4362665596 type Work @default.
• W4362665596 citedByCount "0" @default.
• W4362665596 crossrefType "journal-article" @default.
• W4362665596 hasAuthorship W4362665596A5008164811 @default.
• W4362665596 hasAuthorship W4362665596A5025644793 @default.
• W4362665596 hasAuthorship W4362665596A5039029093 @default.
• W4362665596 hasAuthorship W4362665596A5039769355 @default.
• W4362665596 hasAuthorship W4362665596A5060205180 @default.
• W4362665596 hasAuthorship W4362665596A5068214646 @default.
• W4362665596 hasAuthorship W4362665596A5088555356 @default.
• W4362665596 hasBestOaLocation W43626655961 @default.
• W4362665596 hasConcept C126322002 @default.
• W4362665596 hasConcept C126894567 @default.
• W4362665596 hasConcept C159641895 @default.
• W4362665596 hasConcept C164705383 @default.
• W4362665596 hasConcept C2776301958 @default.
• W4362665596 hasConcept C2777288759 @default.
• W4362665596 hasConcept C2778653478 @default.
• W4362665596 hasConcept C2778661090 @default.
• W4362665596 hasConcept C2779161974 @default.
• W4362665596 hasConcept C2780306776 @default.
• W4362665596 hasConcept C71924100 @default.
• W4362665596 hasConcept C72563966 @default.
• W4362665596 hasConceptScore W4362665596C126322002 @default.
• W4362665596 hasConceptScore W4362665596C126894567 @default.
• W4362665596 hasConceptScore W4362665596C159641895 @default.
• W4362665596 hasConceptScore W4362665596C164705383 @default.
• W4362665596 hasConceptScore W4362665596C2776301958 @default.
• W4362665596 hasConceptScore W4362665596C2777288759 @default.
• W4362665596 hasConceptScore W4362665596C2778653478 @default.
• W4362665596 hasConceptScore W4362665596C2778661090 @default.
• W4362665596 hasConceptScore W4362665596C2779161974 @default.
• W4362665596 hasConceptScore W4362665596C2780306776 @default.
• W4362665596 hasConceptScore W4362665596C71924100 @default.
• W4362665596 hasConceptScore W4362665596C72563966 @default.
• W4362665596 hasIssue "1" @default.
• W4362665596 hasLocation W43626655961 @default.
• W4362665596 hasLocation W43626655962 @default.
• W4362665596 hasLocation W43626655963 @default.
• W4362665596 hasOpenAccess W4362665596 @default.
• W4362665596 hasPrimaryLocation W43626655961 @default.
• W4362665596 hasRelatedWork W1544023406 @default.
• W4362665596 hasRelatedWork W1974378936 @default.
• W4362665596 hasRelatedWork W2046899919 @default.
• W4362665596 hasRelatedWork W2058466993 @default.
• W4362665596 hasRelatedWork W2124543160 @default.
• W4362665596 hasRelatedWork W2140445493 @default.
• W4362665596 hasRelatedWork W3011378569 @default.
• W4362665596 hasRelatedWork W3133946270 @default.
• W4362665596 hasRelatedWork W393698729 @default.
• W4362665596 hasRelatedWork W4280508227 @default.
• W4362665596 hasVolume "21" @default.
• W4362665596 isParatext "false" @default.
• W4362665596 isRetracted "false" @default.
• W4362665596 workType "article" @default.